G. Hasko et al., MODULATION OF LIPOPOLYSACCHARIDE-INDUCED TUMOR-NECROSIS-FACTOR-ALPHA AND NITRIC-OXIDE PRODUCTION BY DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS IN MICE, Immunology letters, 49(3), 1996, pp. 143-147
The effects of various agonists and antagonists of dopamine D-1 and D-
2 receptors on lipopolysaccharide (LPS)-induced tumor necrosis Factor-
alpha (TNF-alpha) and nitric oxide (NO) production was investigated in
mice. Pretreatment of animals with bromocryptine or quinpirole, agoni
sts of dopamine D-2 receptors caused a blunting of both the TNF-alpha
and NO responses to LPS injected intraperitoneally. Sulpiride, an anta
gonist of dopamine D-2 receptors, decreased the LPS-induced TNF-alpha
plasma levels in a dose-dependent manner and inhibited the LPS-induced
NO production by peritoneal macrophages. Bromocryptine or quinpirole
blunted both the TNF-alpha and NO response to LPS. SCH-23390, an antag
onist of dopamine D-1 receptors did not alter LPS-induced TNF-alpha pr
oduction, but inhibited LPS-induced NO production. These results indic
ate that while the D-2 subtype of dopamine receptors is involved in th
e modulation of both LPS-induced TNF-alpha and NO production, dopamine
D-1 receptors only regulate the production of NO. Since several drugs
possess effect on dopamine D-2 receptors, the present observations ma
y be of clinical relevance.